Orexigen Therapeutics Inc. (NASDAQ:OREX), Intrexon Corp. (NYSE:XON) and Voltari Corp. (NASDAQ:VLTC) ended the day well in the green this Tuesday. Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC), Solazyme Inc. (NASDAQ:SZYM) and Allied Nevada Gold Corp. (NYSEMKT:ANV), on the other hand, hit market close in the red.
The Odey Special Situations Fund was down 0.27% for April, compared to its benchmark, the MSCI World USD Index, which was up 4.65%. For the first four months of the year, the fund is up 8.4%, while its benchmark returned 9.8%. Q1 2021 hedge fund letters, conferences and more The Odey Special Situations Fund is Read More
Orexigen Therapeutics Inc. soared +31.95% after the drug maker said its diet pill has cardiovascular benefits. Regulators criticized the firm for releasing the data; however, investors seem not to be concerned. Farallon Capital has a stake in the biotech company.
Intrexon surged +19.72%, ending the day priced at $48.15. The stock, a Dan Loeb pick, has climbed nearly +75% year-to-date.
Carl Icahn investment Voltari Corp. rallied +14.4% to $0.94 this Tuesday and is up +43.88% for the year. It’s still trading far away from its 52-week high of $3.96.
Cyclacel Pharmaceuticals Plunges
Cyclacel Pharmaceuticals plunged -15.98%, ending the day at $1.42. Despite today’s dip, it’s up +147.47% over the past month. Billionaire Wilbur Ross has a small stake in the firm.
Solazyme Inc. tumbled -7.46% today. A maker of renewable oils and other bioproducts, the company recently won IP arbitration over a failed joint venture – news that broke yesterday. Chase Coleman’s Tiger Global has a 0.02% allocation in the company.
The share price of Allied Nevada Gold Corp. fell -7.29% to $0.86 – just cents away from its 52-week low of $0.72. John Paulson has a position in the firm.